장마감
Log in Sign up
7월 30일 · 실적분석
실적분석

Cohu ($COHU) Q2 2026 Earnings Analysis — Revenue and Adjusted EPS Top Expectations; Shares Rally After-Hours on Upbeat Guidance

COHU Cohu 실적 요약

Cohu ($COHU) reported Q2 2026 revenue of $149 million and adjusted EPS of $0.26, beating market estimates of $144 million in revenue and $0.14 in EPS. Revenue grew 38% year over year, and Q3 revenue guidance was set at $170 million (±$7 million). The company also raised its annual high-performance computing revenue estimate tied to artificial intelligence to $100–110 million. With both results and the outlook coming in ahead of expectations, shares reacted strongly in after-hours trading.

📌

Earnings Scorecard

Revenue: $149 million (+38% YoY; estimate $144 million) ✅ Beat
EPS: Adjusted $0.26 (estimate $0.14) ✅ Beat
Guidance: Raised — Q3 revenue $170 million (±$7 million); annual high-performance computing revenue estimate lifted to $100–110 million
Stock Reaction: After-hours +16.92% ($54.31) — as of 07:07 KST, 07-31
📌

What Went Well

Revenue surprise: $149 million topped the $144 million estimate; +38% YoY
Sharp improvement in adjusted earnings: Adjusted EPS of $0.26 well above the $0.14 estimate
AI and utilization: Test cell utilization around 80%; annual AI opportunity around $850 million
Cohu (COHU), which makes semiconductor test and inspection equipment, posted Q2 revenue of $149 million, up 38% from the same period a year earlier (about $108 million) and a step up from the prior quarter's $125 million. The figure is only modestly above the $144 million consensus, but the wide year-over-year growth gap makes it easy to read as a sign of a cyclical recovery.
On the earnings side, adjusted (non-GAAP) net income came in at $14.1 million, or $0.26 per share, well ahead of the $0.14 estimate. Given that Q1 adjusted EPS was just $0.01, the speed of the quarter-to-quarter profitability recovery stands out. Gross margin was reported at 45.4% on a GAAP basis and 45.5% on an adjusted basis.
Management cited broad improvement across the end market and said estimated test cell utilization rose sequentially to roughly 80% by the end of June. The pipeline for AI-driven computing opportunities was lifted to about $850 million annually, with management highlighting adoption of the Eclipse test handler for high-power processors used in data centers as a growth driver.
📌

What Fell Short

GAAP still near break-even: GAAP net loss of about $0.2 million, or $0.00 per share
Gap between adjusted and GAAP: One-time items and amortization drive the difference
Cyclical and customer concentration risk: Semiconductor equipment demand cyclicality and dependence on a few large customers remain
Even though the adjusted figures showed a wider profit, on a GAAP basis the company was essentially at break-even with a Q2 net loss of about $0.2 million, or $0.00 per share. When comparing directly with the $0.14 adjusted consensus, the adjusted figures are the right reference; looking only at GAAP can give a different feel.
Stock-based compensation, acquired intangible amortization, restructuring charges, and similar items are excluded from the adjusted figures, so the gap between the two measures can persist structurally. Beginner investors should be cautious about treating "$0.26 per share" as the same as cash earnings.
Given the business mix, the semiconductor capex cycle and a concentrated customer base can amplify earnings swings. The midpoint of Q3 revenue guidance is higher than Q2, but if shipments or revenue recognition slip, or if a key customer's orders wobble, results could tilt toward the lower end of guidance (around $163 million).
📌

What Management Said

"Second-quarter results reflected broad-based improvement across the end market, with revenue up 38% year over year and estimated test cell utilization improving to roughly 80% as of the end of June." — Luis Müller, President and CEO

Management's tone leans more toward confidence than defensiveness. President and CEO Luis Müller pointed to a recovery across the end market and improving test cell utilization, citing not just the headline numbers but also utilization as a real-time read on the field. He put AI and data center customer momentum front and center, raised the annual high-performance computing revenue estimate, and tied differentiated product adoption — the Eclipse handler and T-Core active thermal control — to specific drivers.
What the market welcomed was less the earnings beat itself and more the interpretation that the beat is tied to the AI equipment demand and rising utilization story rather than a one-off bounce. That said, the next-quarter guidance the company disclosed is centered on revenue, and per-share guidance is not in this release. Investors should keep the company's outlook and sell-side EPS estimates separate rather than mixing them.
📌

Market Reaction and What to Watch Next

The after-hours surge looks less like a reaction to a slightly beat quarter and more like the combination of simultaneous revenue and adjusted earnings surprises, a step-up in next-quarter revenue expectations, and concrete numbers (a higher annual revenue estimate and a larger opportunity pipeline) reinforcing the AI and high-performance computing story. With utilization at 80% thrown in as a real-time field metric, expectations that operating leverage can accelerate after a cyclical bottom appear to have been priced in.
Still, the stock had already rallied in the regular session on the report day before reacting again after hours, so at the next open both profit-taking and "guidance already priced in" debate could surface at the same time. Beginner investors should treat after-hours volatility as confirmed gains; better to track whether next-quarter revenue actually lands on track and whether AI-linked revenue becomes more visible in the numbers.
Check whether Q3 actual revenue lands within the company's range (midpoint $170 million, ±$7 million).
Watch whether AI and data center orders and revenue accumulate along the path implied by the $100–110 million annual high-performance computing revenue estimate.
Track whether test cell utilization holds near 80% or moves higher, with gross margin and adjusted earnings improving alongside.
시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.

🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다
오늘의 픽 보기 →